BIOCON, NOBEX CORP TIE UP FOR CARDIOVASCULAR DRUG

Biotechnology firm Biocon Ltd. said on Tuesday it has tied up with U.S.-based Nobex Corporation to develop an oral peptide product to treat cardiovascular diseases. Bangalore-based Biocon said in a statement the two companies planned to make an investigational new drug filing for the oral human brain-type natriuretic peptide in 2007 and start clinical trials later that year.

Reuters (http://in.today.reuters.com/news/newsArticle.aspx?type=businessNews&storyID=2005-08-23T173057Z_01_NOOTR_RTRJONC_0_India-213608-1.xml)